These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 16738955)

  • 41. CD20-depleting therapy in autoimmune diseases: from basic research to the clinic.
    Perosa F; Prete M; Racanelli V; Dammacco F
    J Intern Med; 2010 Mar; 267(3):260-77. PubMed ID: 20201920
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Oral tolerance in the control of experimental models of autoimmune disease.
    Staines NA; Harper N
    Z Rheumatol; 1995; 54(3):145-54. PubMed ID: 7660685
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Biological therapy of arthritis and systemic autoimmune diseases].
    Tamási L; Szekanecz Z
    Orv Hetil; 2007 Apr; 148 Suppl 1():63-70. PubMed ID: 17430797
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The autoimmune pathogenesis of rheumatoid arthritis: role of autoreactive T cells and new immunotherapies.
    VanderBorght A; Geusens P; Raus J; Stinissen P
    Semin Arthritis Rheum; 2001 Dec; 31(3):160-75. PubMed ID: 11740797
    [TBL] [Abstract][Full Text] [Related]  

  • 45. CD20 therapies in multiple sclerosis and experimental autoimmune encephalomyelitis - Targeting T or B cells?
    Agahozo MC; Peferoen L; Baker D; Amor S
    Mult Scler Relat Disord; 2016 Sep; 9():110-7. PubMed ID: 27645355
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Targeting B cells in treatment of autoimmunity.
    Franks SE; Getahun A; Hogarth PM; Cambier JC
    Curr Opin Immunol; 2016 Dec; 43():39-45. PubMed ID: 27718447
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Targeting B Cells and Plasma Cells in Autoimmune Diseases.
    Hofmann K; Clauder AK; Manz RA
    Front Immunol; 2018; 9():835. PubMed ID: 29740441
    [TBL] [Abstract][Full Text] [Related]  

  • 48. B cells as a therapeutic target in autoimmune diseases other than rheumatoid arthritis.
    Looney RJ
    Rheumatology (Oxford); 2005 May; 44 Suppl 2():ii13-ii17. PubMed ID: 15851522
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Monoclonal antibodies and fusion proteins and their complications: targeting B cells in autoimmune diseases.
    Lee S; Ballow M
    J Allergy Clin Immunol; 2010 Apr; 125(4):814-20. PubMed ID: 20371395
    [TBL] [Abstract][Full Text] [Related]  

  • 50. B-cell-directed therapy for inflammatory skin diseases.
    Nagel A; Hertl M; Eming R
    J Invest Dermatol; 2009 Feb; 129(2):289-301. PubMed ID: 19148218
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [New approaches to the regulation of autoimmune disease].
    Kotake S; Matsuda H
    Nippon Ganka Gakkai Zasshi; 1994 Feb; 98(2):121-9. PubMed ID: 8109455
    [TBL] [Abstract][Full Text] [Related]  

  • 52. T-cell-based immunotherapy of autoimmune diseases.
    Ulivieri C; Baldari CT
    Expert Rev Vaccines; 2013 Mar; 12(3):297-310. PubMed ID: 23496669
    [TBL] [Abstract][Full Text] [Related]  

  • 53. B cell targeted therapy in autoimmunity.
    Blank M; Shoenfeld Y
    J Autoimmun; 2007; 28(2-3):62-8. PubMed ID: 17391915
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Abnormalities of lymphocytes in autoimmune-prone mice].
    Inaba M; Ikehara S
    Tanpakushitsu Kakusan Koso; 1990 Feb; 35(2):158-67. PubMed ID: 2181534
    [No Abstract]   [Full Text] [Related]  

  • 55. B cell depletion therapy in systemic rheumatic diseases: different strokes for different folks?
    Stohl W; Looney RJ
    Clin Immunol; 2006 Oct; 121(1):1-12. PubMed ID: 16697258
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Depletion of CD8+ cells exacerbates organ-specific autoimmune diseases induced by CD4+ T cells in semiallogeneic hosts with MHC class II disparity.
    Saitoh T; Ikarashi Y; Ito S; Watanabe H; Fujiwara M; Asakura H
    J Immunol; 1990 Nov; 145(10):3268-75. PubMed ID: 2121823
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Novel therapies for memory cells in autoimmune diseases.
    Bhargava P; Calabresi PA
    Clin Exp Immunol; 2015 Jun; 180(3):353-60. PubMed ID: 25682849
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The immunopathogenesis of rheumatoid arthritis.
    Trentham DE
    J Rheumatol Suppl; 1985 Dec; 12 Suppl 12():7-10. PubMed ID: 3007756
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antibodies to OX-40 (CD134) can identify and eliminate autoreactive T cells: implications for human autoimmune disease.
    Weinberg AD
    Mol Med Today; 1998 Feb; 4(2):76-83. PubMed ID: 9547794
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification and characterization of the antigen presenting cell in rat autoimmune myocarditis: evidence of bone marrow derivation and non-requirement for MHC class I compatibility with pathogenic T cells.
    Ratcliffe NR; Wegmann KW; Zhao RW; Hickey WF
    J Autoimmun; 2000 Nov; 15(3):369-79. PubMed ID: 11040077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.